Global Blood Therapeutics Inc (GBT)

64.83
3.10 4.50
NASDAQ
Prev Close 67.90
Open 68.00
Day Low/High 64.42 / 69.86
52 Wk Low/High 39.95 / 87.54
Volume 839.51K
Exchange NASDAQ
Shares Outstanding 60.94B
Market Cap 4.19B
P/E Ratio N/A
Div & Yield N.A. (N.A)
Take a Chill Pill: If Clinton Wins, Drug-Price Controls Aren't Guaranteed

Take a Chill Pill: If Clinton Wins, Drug-Price Controls Aren't Guaranteed

Such unwarranted fears have depressed the sector, which could bounce back after Nov. 8.

Shark Bites: Two Big Movers

Shark Bites: Two Big Movers

'If there are worries about the market topping out it isn't evident in [today's] price action.'

Shark Bites: Versartis Is a Biotech Worth Tracking

Shark Bites: Versartis Is a Biotech Worth Tracking

Biotechnology stocks can be risky but it's helpful to track them over time.

Just Can't Shoot This Market Down

Just Can't Shoot This Market Down

Today's action: If you can't beat 'em, join 'em.

Shark Bites: Market Responds With 'Deutsche Who?'

Shark Bites: Market Responds With 'Deutsche Who?'

Report of settlement turns the market.

My Small-Cap Biotech Stock of the Week

My Small-Cap Biotech Stock of the Week

Shares of Global Blood Therapeutics currently are in the bargain bin.

Selling Into Strength Can Be a Great Strategic Move

Selling Into Strength Can Be a Great Strategic Move

We are seeing lower lows in the indices as I write.

I Am One of the Underinvested Bulls Right Now

I Am One of the Underinvested Bulls Right Now

It's challenging to put cash to work but I'll keep digging.

Shark Bites: Putting Etsy in My Basket

Shark Bites: Putting Etsy in My Basket

Meanwhile, I continue to hold long-term favorites like Energy Recovery, TPI Composites and Aratana.

These Biotech Names Are on My Radar

These Biotech Names Are on My Radar

But I'm expecting that things will slow into the Fed news.

Seeing the Same Old Patterns Ahead of Fed News

Seeing the Same Old Patterns Ahead of Fed News

Buyers expect a dovish Fed and are still trying to put money to work.

Shark Bites: 5 Stocks I Am Playing in This Choppy Action

Shark Bites: 5 Stocks I Am Playing in This Choppy Action

Despite the unsettled market, there are still some interesting picks out there.

Fear of Being Left Out Is Lifting Indices

Fear of Being Left Out Is Lifting Indices

The overall technical condition of the indices remains negative.

Bounce Has Gone Bust Pretty Quickly

Bounce Has Gone Bust Pretty Quickly

If the market closes weak today, it will be marked with an exclamation point.

As Market Bears Feast, Opportunities Develop

As Market Bears Feast, Opportunities Develop

Is the party over? It's time to protect capital.

Watch Out for Lower Lows Now

Watch Out for Lower Lows Now

Upside momentum is limited, but we still aren't seeing any major technical breakdowns.

There Is Still Good Trading in Individual Names

There Is Still Good Trading in Individual Names

Until there is a change in the character of this action, it pays to be bullish.

BioTelemetry, Vonage and TPI Composites Have Dipped

BioTelemetry, Vonage and TPI Composites Have Dipped

Ideally I'd like to buy a negative response to Janet Yellen tomorrow.

Shark Bites: 2 Stocks to Keep on the Radar in This Market Pullback

Shark Bites: 2 Stocks to Keep on the Radar in This Market Pullback

The sudden dearth of momentum will give us some good opportunities, but watch accounts closely.

Rev's Forum: The Bears Are Growling About Signs of Overheating

Rev's Forum: The Bears Are Growling About Signs of Overheating

Make sure you protect those outsized gains; this is a great market for stock picking.

Shark Bites: This Biotech Play Offers a Great Chart Setup

Shark Bites: This Biotech Play Offers a Great Chart Setup

Global Blood Therapeutics is a good example of how tracking a chart and waiting for a setup can work well.

What Does a Winner Look Like?

What Does a Winner Look Like?

If you follow the adage about cutting losses quickly and letting winners run, it is possible to generate some very attractive returns.

I've Taken Some Twitter on the Microsoft-LinkedIn News

I've Taken Some Twitter on the Microsoft-LinkedIn News

Microsoft is doing the deal partly because it can fund it so easily. 

Maybe the Bears Are on to Something

I can't recall every hearing so many negative predictions from big-picture bears.